User contributions
Jump to navigation
Jump to search
- 23:31, 17 October 2013 diff hist -3 m Malignant pleural mesothelioma Text replace - ", et al. " to " et al. "
- 23:31, 17 October 2013 diff hist -61 m Melanoma Text replace - ", et al. " to " et al. "
- 23:31, 17 October 2013 diff hist -7 m Marginal zone lymphoma Text replace - ", et al. " to " et al. "
- 23:30, 17 October 2013 diff hist -20 m Mantle cell lymphoma Text replace - ", et al. " to " et al. "
- 23:28, 17 October 2013 diff hist -16 m Light-chain (AL) amyloidosis Text replace - ", et al. " to " et al. "
- 23:23, 17 October 2013 diff hist -5 m Hodgkin lymphoma, nodular lymphocyte-predominant Text replace - ", et al. " to " et al. "
- 23:23, 17 October 2013 diff hist -8 m Classical Hodgkin lymphoma Text replace - ", et al. " to " et al. "
- 23:23, 17 October 2013 diff hist -4 m Hepatocellular carcinoma Text replace - ", et al. " to " et al. "
- 23:23, 17 October 2013 diff hist -66 m Head and neck cancer Text replace - ", et al. " to " et al. "
- 23:21, 17 October 2013 diff hist -3 m Hairy cell leukemia Text replace - ", et al. " to " et al. "
- 23:18, 17 October 2013 diff hist -19 m HIV-associated lymphoma Text replace - ", et al. " to " et al. "
- 23:15, 17 October 2013 diff hist -4 m Gastric cancer Text replace - ", et al. " to " et al. "
- 23:13, 17 October 2013 diff hist -31 m Follicular lymphoma Text replace - ", et al. " to " et al. "
- 23:13, 17 October 2013 diff hist -1 m Example orders for CapeOx (XELOX) in colon cancer Text replace - ", et al. " to " et al. "
- 23:13, 17 October 2013 diff hist -79 m Esophageal cancer Text replace - ", et al. " to " et al. "
- 23:12, 17 October 2013 diff hist -49 m Colon cancer Text replace - ", et al. " to " et al. "
- 23:12, 17 October 2013 diff hist -61 m Chronic lymphocytic leukemia Text replace - ", et al. " to " et al. "
- 23:11, 17 October 2013 diff hist -22 m Cervical cancer Text replace - ", et al. " to " et al. "
- 23:11, 17 October 2013 diff hist -56 m Anaplastic glioma Text replace - ", et al. " to " et al. "
- 23:11, 17 October 2013 diff hist -7 m CNS lymphoma Text replace - ", et al. " to " et al. "
- 23:11, 17 October 2013 diff hist -71 m Breast cancer Text replace - ", et al. " to " et al. "
- 23:10, 17 October 2013 diff hist -38 m Bone sarcoma Text replace - ", et al. " to " et al. "
- 23:10, 17 October 2013 diff hist -25 m Urothelial carcinoma Text replace - ", et al. " to " et al. "
- 23:09, 17 October 2013 diff hist -4 m Cutaneous basal cell carcinoma Text replace - ", et al. " to " et al. "
- 23:09, 17 October 2013 diff hist -6 m Immune thrombocytopenia Text replace - ", et al. " to " et al. "
- 23:09, 17 October 2013 diff hist -9 m Anal cancer Text replace - ", et al. " to " et al. "
- 23:08, 17 October 2013 diff hist -57 m Aggressive Non-Hodgkin lymphoma Text replace - ", et al. " to " et al. "
- 23:08, 17 October 2013 diff hist -34 m Acute promyelocytic leukemia Text replace - ", et al. " to " et al. "
- 23:08, 17 October 2013 diff hist -24 m Acute myeloid leukemia Text replace - ", et al. " to " et al. "
- 23:08, 17 October 2013 diff hist -13 m B-cell acute lymphoblastic leukemia Text replace - ", et al. " to " et al. "
- 00:36, 18 August 2013 diff hist +47 m MediaWiki:Sidebar billing link
- 00:21, 18 August 2013 diff hist -387 MediaWiki:Sitenotice Undo revision 3736 by Dryang (talk)
- 00:21, 18 August 2013 diff hist +387 MediaWiki:Sitenotice
- 21:29, 28 June 2013 diff hist +77 MediaWiki:Sitenotice
- 23:48, 26 June 2013 diff hist +25 m MediaWiki:Sidebar
- 06:42, 17 June 2013 diff hist +371 m Example orders for weekly 5-FU & Leucovorin in colon cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:42, 17 June 2013 diff hist +371 m Example orders for simplified biweekly 5-FU & leucovorin (sLV5FU2) in colon cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:42, 17 June 2013 diff hist +371 m Example orders for mFOLFOX6-B in colon cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:42, 17 June 2013 diff hist +371 m Example orders for mFOLFOX 6 in colon cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:42, 17 June 2013 diff hist +371 m Example orders for Rituximab (Rituxan) desensitization protocol Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:42, 17 June 2013 diff hist +371 m Example orders for R-CHOP in lymphoma Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:42, 17 June 2013 diff hist +371 m Example orders for Pemetrexed (Alimta) in non-small cell lung cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for Panitumumab (Vectibix) in colon cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for Oxaliplatin (Eloxatin) desensitization protocol Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for Irinotecan (Camptosar) in colon cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for Ipilimumab (Yervoy) in melanoma Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for High-dose Methotrexate (MTX) & Ifosfamide in lymphoma Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for High-dose (HD) IL-2 in renal cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for High-dose (HD) IL-2 in melanoma Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read
- 06:41, 17 June 2013 diff hist +371 m Example orders for FOLFIRI in colon cancer Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read